Barclays upgraded the rating of medical care group CVS Health from "Neutral" to "Shareholding", and increased the target price from $63 to $82.
巴克莱上调CVS Health的评级及目标价
Barclays has raised the rating and target price of CVS Health.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated